mRNA Flu Vaccine: Promising Results in Clinical Trials
Pfizer and Moderna report promising results for mRNA flu vaccines in phase 3 trials, outperforming traditional vaccines. mRNA vaccines could be a valuable tool against influenza.
Pfizer and Moderna report promising results for mRNA flu vaccines in phase 3 trials, outperforming traditional vaccines. mRNA vaccines could be a valuable tool against influenza.